Physician profile
Anirudh Kumar
NPI 1790103166
$12,110.40
in general payments reported to CMS, 2019-2025
15 companies · $712 in 2025
The $712 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,105 · 2021: $505 · 2022: $2,340 · 2023: $3,841 · 2024: $3,608 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,232 · Travel and Lodging: $3,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,232.39 |
| Travel and Lodging | $3,928.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,358.34 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $3,459.71 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $1,551.13 | 2023-2025 | Mitraclip |
| Boston Scientific Corporation | $1,473.00 | 2020-2022 | |
| Abiomed | $737.01 | 2022-2024 | Impella |
| Shockwave Medical, INC | $106.55 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $90.91 | 2022 | |
| Cardiva Medical, INC. | $77.04 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Novartis Pharmaceuticals Corporation | $73.54 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.08 | 2022-2024 | Lifevest |
| Cardiovascular Systems INC. | $56.51 | 2021-2022 | |
| Pfizer INC. | $36.92 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.65 | 2022 | |
| Teleflex LLC | $16.01 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anirudh Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.